Vivos Therapeutics, Inc. - 10-Q Filing

Vivos Therapeutics filed a Form 10-Q for the quarterly period ended March 31, 2026, providing unaudited financial results and updates on its operations.

SEC EDGAR ·

Tickers: $VVOS

Read the full article at SEC EDGAR

More Regulatory news